மலர் க்ராஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from மலர் க்ராஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In மலர் க்ராஸ் Today - Breaking & Trending Today
Share this article Share this article LIEGE, Belgium, June 3, 2021 /PRNewswire/ Amyl Therapeutics ( Amyl ), a preclinical stage biotechnology company developing its amyloid fibrils specific technology platform named ClariTY for the treatment of all forms of Amyloidosis, today announced that it has successfully closed a €18.3 million Series A financing. The funding round comprises €8.6 million in equity led by Noshaq - a regional Belgian private-public fund - with support from Merieux Participations, Sambrinvest and other private investors; and €9.7 million in non-dilutive funding from the DG06 – a key policy-design and implementing body for research and innovation policy in the Walloon region of Belgium. ....
The round is comprised of: €8.6m in equity led by Noshaq – a regional Belgian private-public fund – with participation from Merieux Participations, Sambrinvest and other private investors; and €9.7m in non-dilutive funding from the DG06 – a key policy-design and implementing body for research and innovation policy in the Walloon region of Belgium. Following the closing of the financing, Dr. Pierre Vandepapelière (Amyl’s Co-Founder, CEO and CMO), Florent Gros (Amyl’s Co-Founder and Chairman), Dr. Valérie Calenda (Managing Partner at Merieux Equity Partners), Kenneth Buckfire (President of Miller Buckfire & Co.) and Amel Tounsi (Investment Manager at Noshaq) have joined the Board of Directors. ....